232 related articles for article (PubMed ID: 1977948)
1. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma].
Tsukioka K; Nakamata M; Kondo A; Hashimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948
[TBL] [Abstract][Full Text] [Related]
2. Oral doxophylline in patients with chronic obstructive pulmonary disease.
Villani F; De Maria P; Ronchi E; Galimberti M
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
[TBL] [Abstract][Full Text] [Related]
3. A study with cumulative doses of formoterol and salbutamol in children with asthma.
Foucard T; Lönnerholm G
Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
[TBL] [Abstract][Full Text] [Related]
4. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.
van Baak MA; de Hon OM; Hartgens F; Kuipers H
Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma].
Kokubu H
Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230
[TBL] [Abstract][Full Text] [Related]
6. Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol.
Dottorini ML; Tantucci C; Peccini F; Grassi V; Sorbini CA
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):438-43. PubMed ID: 8897082
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilator intake and plasma levels on admission for severe acute asthma.
Janson C; Boe J; Boman G; Mossberg B; Svedmyr N
Eur Respir J; 1992 Jan; 5(1):80-5. PubMed ID: 1577155
[TBL] [Abstract][Full Text] [Related]
8. Inhalation therapy with magnesium sulfate and salbutamol sulfate in bronchial asthma.
Meral A; Coker M; Tanaç R
Turk J Pediatr; 1996; 38(2):169-75. PubMed ID: 8701480
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
[TBL] [Abstract][Full Text] [Related]
10. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol.
Vidgren M; Silvasti M; Korhonen P; Kinkelin A; Frischer B; Stern K
Arzneimittelforschung; 1995 Jan; 45(1):44-7. PubMed ID: 7893268
[TBL] [Abstract][Full Text] [Related]
11. Oral fenoterol versus sustained release theophylline in adult asthmatics.
Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
[TBL] [Abstract][Full Text] [Related]
12. Which patients benefit from adding theophylline to beta 2-agonist treatment in severe acute asthma?
Janson C; Boman G; Boe J
Ann Allergy; 1992 Aug; 69(2):107-10. PubMed ID: 1354948
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the bronchodilator effects of broxaterol and salbutamol.
Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
[TBL] [Abstract][Full Text] [Related]
14. Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction.
Koskela HO; Kiviniemi V; Purokivi MK; Taivainen AH; Tukiainen HO
Respir Med; 2006 Oct; 100(10):1760-6. PubMed ID: 16563715
[TBL] [Abstract][Full Text] [Related]
15. [The evaluation of efficacy and tolerability of salbutamol administered by nebulization in patients with stable severe bronchial asthma].
Kroczyńska-Bednarek J; Kwiatkowska S; Zagdańska R; Zieba M; Tymińska K; Grzelewska-Rzymowska I
Pneumonol Alergol Pol; 2001; 69(1-2):84-92. PubMed ID: 11475562
[TBL] [Abstract][Full Text] [Related]
16. Salbutamol in the treatment of asthmatic children. A comparison of oral and inhalation therapy alone and in combination.
Berg IM; Berg T; Ringqvist I
Eur J Respir Dis; 1982 Jul; 63(4):305-9. PubMed ID: 7117428
[TBL] [Abstract][Full Text] [Related]
17. High-dose MDI salbutamol treatment of asthma in the ED.
Rodrigo C; Rodrigo G
Am J Emerg Med; 1995 Jan; 13(1):21-6. PubMed ID: 7832947
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacodynamics of inhalation broncholytic agents introduced in a single dose by nebulizer in patients with severe exacerbation of bronchial asthma].
Tsoĭ AN; Apkhipov VV
Ter Arkh; 2002; 74(3):17-21. PubMed ID: 11980113
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
Windom H; Grainger J; Burgess C; Crane J; Pearce N; Beasley R
N Z Med J; 1990 Jun; 103(891):259-61. PubMed ID: 1972557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
